Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Floium Ginkgo Extract and Tetramethylpyrazine Sodium Chloride Injection for Acute Ischemic Stroke
ChiCTR1900028391Phase 4Recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Aug 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of folium ginkgo extract + tetramethylpyrazine sodium chloride in ischemic stroke (2 arms), sponsored by First Hospital of China Medical University. Primary endpoint: Reperfusion improvement. Started Aug 2019; status: recruiting.
02
Drugs
folium ginkgo extract + tetramethylpyrazine sodium chloride
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR1900028391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028391.